MedPath

Tolerance and Prebiotic Activity of Arabinoxylan-Oligosaccharides in Healthy Subjects

Phase 4
Completed
Conditions
Healthy
Registration Number
NCT00852813
Lead Sponsor
KU Leuven
Brief Summary

The purpose of the study is to evaluate the tolerance of a higher dose of arabinoxylan-oligosaccharides (AXOS) and their prebiotic activity in healthy subjects.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • healthy
  • 18-45 years
  • regular eating pattern
Exclusion Criteria
  • gastrointestinal complaints
  • antibiotic intake
  • medication influencing gut transit or microbiota
  • abdominal surgery
  • pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Department of Gastrointestinal Research, Laboratory Digestion and Absorption

🇧🇪

Leuven, Belgium

© Copyright 2025. All Rights Reserved by MedPath